$CABA Cabaletta Bio ripping premarket! 🚀 Up 18% 🔹 Fresh momentum after pricing a $150M underwritten offering 📈 🔹 Funding strengthens the balance sheet as Ca

$CABA Cabaletta Bio ripping premarket! 🚀 Up 18% 🔹 Fresh momentum after pricing a $150M underwritten offering 📈 🔹 Funding strengthens the balance sheet as Cabaletta pushes deeper into autoimmune cell therapy 🧬 🔹 Company is focused on targeted CAR T therapies designed for autoimmune diseases 🔬 …